← Leaderboards
Harry C Hwang
Fred Hutchinson Cancer Research Center
$636,920
Attributed
$636,920
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $127.4K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$636,920 · 1
By mechanism
K08$636,920 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Harmit S Malik$7,050,387
- James M Roberts$4,397,303
- Robert Neil Eisenman$37,903,199
- Gavin Ha$4,673,787
- Bruce E Clurman$16,275,505
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureBone Marrow TransplantationProtein KinaseBlood /Lymphatic NeoplasmCell ProliferationNeoplasm /Cancer GeneticsLymphomaLaboratory MouseProtooncogeneTerminal Nick End LabelingTumor Suppressor GenesLeukemiaPolymerase Chain ReactionWestern BlottingsApoptosisFlow CytometryCell TransformationCell Cycle ProteinsHigh Throughput TechnologyEnzyme InhibitorsGenetically Modified AnimalsCell CountCdkn2a GeneCdk2 Protein, Human
Grant awards (5)
Pathways in p27-associated hematolymphoid malignancy$127,384
K08 · FY2007 · HL · contact PI
Pathways in p27-associated hematolymphoid malignancy$127,384
K08 · FY2006 · HL · contact PI
Pathways in p27-associated hematolymphoid malignancy$127,384
K08 · FY2005 · HL
Pathways in p27-associated hematolymphoid malignancy$127,384
K08 · FY2004 · HL
Pathways in p27-associated hematolymphoid malignancy$127,384
K08 · FY2003 · HL